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Abstract. Diabetic nephropathy has an unclarified pathogenesis, with multifactorial aetiology which includes metabolic and
haemodynamic abnormalities, aberrant signaling of numerous cytokines or growth factors and genetic susceptibility. Inflammation and low
birth weight seems to be predisposing factors for diabetic nephropathy. In both processes levels of L-selectin (CD62L) may play an important
role. The genetic heritability of diabetic nephropathy and CD62L levels sustain the investigation of relationship between LECAM
polymorphisms and the disease risk. The aim of the study was to investigate a possible relationship between Pro213Ser polymorphism in
LECAM-1 gene and advanced stages of diabetic nephropathy in type 1 diabetes. We enrolled unrelated Caucasian patients with type 1 diabetes
mellitus, fall into control group – diabetic patients with duration of disease over 20 years without microalbuminuria (n = 83) and
nephropathy group – patients with overt nephropathy or end stage renal disease – ESRD (n = 121). Pro213Ser polymorphism
genotyping was achieved using PCR-RFLP technique. Genotype spread analysis indicates that ProSer and SerSer are more frequent
in the nephropathy group (ProSer = 41.95% and SerSer = 6.02 %), compared with the control group (ProSer = 20.53% and SerSer =
1.73%). The corrected OR's due to the small number of patients pointed the possibility that the 213Ser is the risk allele (ORSer =
1.634; p=0.04), and 213Pro is the protective one (ORPro = 0.602; p=0.04) regarding diabetic nephropathy. Thus our results suggest a
possible association between the P213S polymorphism and advanced stages of diabetic nephropathy in type 1 diabetic patients.
Additional researches are required in order to acknowledge the mentioned results and to clarify the mechanism by which this
polymorphism intervenes in the disease pathogenesis.
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INTRODUCTION
Diabetic nephropathy (DN) is a condition
characterised by the decrease of the glomerular
filtration rate and persistent albuminuria, accompanied
by high blood pressure as well as elevated mortality
caused by cardiovascular diseases. Currently, the
pathogenesis of this disorder is not fully understood.
The multifactorial aetiology of ND includes metabolic
and haemodynamic abnormalities, aberrant signalling
of numerous cytokines or growth factors and genetic
susceptibility.
Acute hyperglycaemia (postprandial) determines
endothelial dysfunction and doubles the production of
reactive oxygen species by the polymorphonuclear and
mononuclear leucocytes [32]. The free radicals
stimulate the proinflammatory cytokines release which
induces the adhesion molecules expression [25],
probably by nuclear factor – Kb [2]. Chronic
hyperglycaemia and mechanic stress caused by the
intraglomerular high blood pressure can independently
lead to the increased expression and to release of
monocitary chemoatracting protein gene (MCP-1) [8,
9], followed by glomerular infiltration [27]. Therefore,
acute or chronic hyperglycaemia and mechanic stress
determines inflammation triggering [17], activation of
the immune cells with cytokines release, followed by
increased prosclerotic response to TGF ȕ1 [23].
Prevention of the glomerular monocitary infiltration
and immune cells activation has antiproteinuric and
renoprotective effect [14, 31].
Glomerular infiltration supposes recruitment of
monocyctes, neutrophils and then lymphocytes to the
vascular wall, followed by its crossing through
diapedesis and cells movement through the interstitial
spaces due to chemoattraction. Adherence and cells
rolling on the vascular wall require an increased
circulating level of L-selectin (CD62L) and the
interaction between CD62L from neutrophils surface
and E-selectin expressed on the endothelial cells [10,
24, 33]. This molecule is also similarly involved in the
interaction of other cells important for glomerular
infiltration [11]. In addition it has been found that the
circulating levels of CD62L are high both in patients
with type 1 DM [29] and in apparently healthy, first
degree relatives [15], but the expression of this
molecule is lower at the lymphocytes and neutrophils
surface in type 2 diabetic patients with DN, compared
with those who have not microvascular complications
[19]. Thus, the role of CD62L in pathogenesis of
diabetes mellitus (DM) and its complications remains
to be clarified.
Since only 30-40% of the overall patients with type
1 DM develop clinically DN, it is supposed that there is
a genetic predisposition for this complication, fact
acknowledged by the increased incidence of the disease
in studies with normo- and macroalbuminuric pairs of
twins [3, 28]. Genetic heritability of the DN and
CD62L levels, corroborated with a possible
involvement of L-selectin in the pathogenesis of this
disease, sustain the investigation of functional
mutations at the level of this gene in patients with type
1 DM and different degree of vascular complications.
The L-selectin gene (SELL, LECAM-1) has ten
exons and is located 1(q23-q25) [22]. Polymorphism
rs4987310 from the sixth exon (coding for short
repetitive consensus domain 1) consists in a C/T
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level of the 213 codon from Proline to Serine. This
polymorphism seems to influence the interaction
between leucocytes and endothelium [18], the risk of
Graves’ disease in Chinese population [4] and of DN
[12] but not retinopathy in Japanese population with
type 2 DM [13].
The purpose of this research is to investigate if
Pro213Ser polymorphism in LECAM-1 gene is
associated with advanced chronic renal disease in type
1 DM patients.
MATERIALS AND METHODS
A number of 204 unrelated Caucasian patients with
type 1 DM have been included in the study. The study
enrolment was performed after an informed consent
was signed, in accordance with the declaration of
Helsinki. They have been considered as control group
(83 patients with diabetes duration over 20 years
without microalbuminuria) or nephropathy group (121
patients with overt nephropathy or end stage renal
disease  –  ESRD).  The  diagnostic  of  type  1  DM  was
based on inaugural ketoacidotic coma, insulin
treatment during the first 12 months from this episode
and the level of peptide C < 0.3 nmol/l. Patients
included in the nephropathy group have a glomerular
filtration rate (GFR)  59 ml/min/1,73 m
2 and
albuminuria ! 300 mg/l in the first morning urine
sample and the control group include patients with
GFR between 90 and 120 ml/min/1,73 m
2 and without
microalbuminuria.
The  genomic  DNA  was  extracted  from  the
peripheral venous blood of patients (2ml), using a
classical protocol and then stored at -20°C. The
Pro213Ser (rs4987310) polymorphism genotyping has
been achieved by PCR-RFLP technique. A fragment of
186 bp was amplified, using the following primers: F 5c
- TGA TTC AGT GTG AGC CTT TG - 3c and R 5c -
CTT GAC AGG TTG GTT CTG - 3c [12]. The PCR
mix included: genomic DNA 1 μl, PCR Buffer (2X) 5
μl, dNTP 0.04 μl, F and R primers 0.04 μl each, Taq
polymerase 0.1 μl, water 3.78 μl, working within a
final volume of 10 μl. PCR reaction was performed
using a Perkin Elmer Gene Amp PCR system 2400.
PCR program had an initial denaturation stage of 2
minutes  at  72  degrees  95°C  followed  by  35  cycles  -
1min. at 90°C, 1 min. at 60°C, 50 sec. at 72°C and a
final elongation of 2 minutes at 72 degrees. The quality
of amplicons has been checked by means of
electrophoresis (agarose 2%, TBE 1x, 5V/cm). Five μl
of each amplicon was restricted using 5U of Hph I
enzyme (New England Biolabs, Inc. Beverly, USA) for
three hours at 37°C. The restriction fragments have
been viewed in UV light, after electrophoresis in 12%
polyacrylamide gel and ethidium bromide staining.
The statistic analysis of genotypes spread within
the two groups included the testing for deviation from
Hardy-Weinenberg equilibrium, using “Pearson's chi-
square test”. The inbreeding coefficient was also
calculated for the studied population. The Odds ratio
(OR) and the 95% confidence interval (95% CI)
starting from the contingency tables were calculated in
order to evaluate the association between LECAM-1
genotypes and DN. Calculations for the control case-
study were achieved using the DeFinetti
(http://ihg.gsf.de) informatics program. The p value
considered as being statistically significant was  0.05.
RESULTS
PCR-RFLP analysis has showed the presence of all
three genotypes of P213S polymorphism in the L-
selectin gene. The presence of T (213Ser) allele
generates a restrictio n s ite f o r H ph I e nzy me and the
amplicon digestion generates two fragments of 142 bp
and 44 bp. When C (Pro213) allele is present, the
restriction situs is not created, the amplicon is not
digested and it maintains its size of 186 bp (Figure 1).
Figure 1. The electrophoresis results for Pro213Ser polymorphism
(lines 1, 2: ProPro genotype; lines 3: DNA leader 100 bp
- Fermantas, lines 4, 5: SerSer genotype, lines 6, 7 ProSer
genotype).
Testing Hardy-Weinberg equilibrium has shown
that there was no significant deviation of P213S
genotypes distribution from the balance condition,
either for the control group (X
2 = 0.06, p=0.81) or for
the nephropathy group (X
2 = 0.29, p=0.59). There is a
very low inbreeding coefficient calculated by us which
represents an argument for validating the groups
selected for our research. Genotypes spread analysis
indicates that ProSer and SerSer are more frequent in
our nephropathy group compared with controls without
diabetic renal disease (ProSer: 36.36% vs. 24.09% and
SerSer: 4.13 % vs 2.40%). Also, the Pro allele
frequency is lower in the nephropathy group compared
with controls (78% vs. 86%) (Table 1).
Calculation of OR, starting from the allelic
frequency, has shown that the Ser allele entails a risk
for diabetic renal disease (OR=1.69, 95% C.I.=1.002-
2.881), while the Pro allele provides protection
(OR=0.58, 95% C.I = 0.347-0.998).
When it is performed the allelic positivity test,
considering the 213Pro as the reference allele, the
presence of a single 213Ser allele entails a significant
statistic risk (p = 0.03) for advanced stages of DN (OR
= 1.88, 95% C.I = 1.028 - 3.465). Under homozygous
form, the 213Ser allele seems to additionally increase
the risk for DN (OR = 2.11), while the 213Pro allele
seems to be protective (OR = 0.47), but the results do
not reach the cut-off of the statistic significance (Table
2).
However, after the application of the required
correction, due to the small number of patients and the
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Table 1. Genotypes spread, alleles frequency and testing deviation from Hardy-Weinberg equilibrium.
         Date
Genotype
Number of genotypes
achieved during the
research
Number of
expected
genotypes
within the
research
Frequency of
genotypes
within the
research
P Allele
frequency
(- SD)
 Inbreeding
coefficient
Statistic
significance -p
Control group – patients with type 1 DM and without DN
ProPro 61 60.73 0.735
ProSer 20 20.53 0.241
SerSer 2 1.73 0.024
0.86
(- 0.028)
0.0258 0.814
Nephropathy group - patients with type 1 DM and DN
ProPro 72 73.02 0.595
ProSer 44 41.95 0.364
SerSer 5 6.02 0.041
0.78
(- 0.026)
-0.0488 0.591
Table 2. Test results for association of Pro213Ser polymorphism in L-selectin gene with DN in the type 1 diabetes mellitus.
Allelic
frequency
difference
Heterozygous Homozygous Allelic positivity Corrected
Odds Ratio
Ser - risk allele
[Pro]<->[Ser] [ProPro]<->[ProSer] [ProPro]<->[SerSer] [ProPro]<->[ProSer+SerSer]
Odds Ratio 1.699 1.864 2.118 1.887 1.634
95% C.I. [1.002-2.881] [0.994-3.496] [0.397-11.307] [1.028-3.465] -
Chi
2 3.93 3.81 0.80 4.25 3.99
p 0.04 0.05 0.37 0.03 0.04
Pro - risk allele
[Ser]<->[Pro] [SerSer]<->[ProSer] [SerSer]<->[ProPro] [ProPro+ProSer]<->[SerSer]
Odds Ratio 0.588 0.880 0.472 0.573 0.602
95% C.I. [0.347-0.998] [0.157-4.929] [0.088-2.520] [0.108-3.025] -
Chi
2 3.93 0.02 0.80 0.44 3.99
p 0.04 0.88 0.37 0.50 0.04
Note: Ser risk allele – Pro allele is considered OR=1; corrected OR– following application of the correction for small batches and Armitage test in order to set the
trend; Pro risk allele – Ser allele is considered OR = 1.
small number of homozygotes for the 213Ser allele, by
Armitage's test (achieved by means of DeFinetti
program), the results are statistically significant. The
corrected ORSer = 1.634 (p=0.04) and ORPro = 0.602
(p=0.04) emphasizes the possibility for the 213Ser
mutant allele to be the risk allele, and the “wild type” –
Pro allele to be protective for advanced stages of DN.
DISCUSSIONS
According to our knowledge, this is the first
research which investigates the association between
Pro213Ser polymorphism, in the L-selectin gene and
D N i n t y p e 1 D M . T h e r e s u l t s s h o w a p o s s i b l e
contribution of this polymorphism to the increased risk
for overt DN or ESRD in patients with type 1 DM. Due
to the relatively limited number of patients, only the
allelic positivity test and the heterozygous condition
for the 213Ser allele have reached the statistic
significance for the risk elevation. Regarding the
SerSer homozygous condition, despite an OR = 2.11,
the statistic significance could not be reached, probably
due to the small number of homozygotes (two in the
control group and five in the nephropathy group). The
significant differences between the alleles frequencies
following applied correction, suggests that there is
!95% probability to achieve similar results to those of
our research. The trend suggests that the Ser allele
increases the risk of overt DN or ESRD development in
type 1 DM patients.
Our results are difficult to explain and correlate
with the already existing data in the literature. The
functional significance of the Pro213Ser
polymorphism is not accurately known, but it seems to
have an impact upon two very important
pathophysiological processes: 1 – the cells interaction
during the intrauterine development; 2 – adherence
between leucocytes and endothelial cells during the
inflammation process.
The proper expression of L-selectin is crucial to
normal placenta implant and development [16, 20] and
thus interferes with the intrauterine development [7,
32]. In addition the mutant LECAM-1 213Ser allele
was associated with a low birth weight [5]. Since
within some populations the low birth weight is a risk
factor for congenital oligonephronia and the DN [6,
26], it is possible that mutations or the abnormal
expression of genes codifying for adherence
molecules, including L-selectin, to interfere with
intrauterine development and DN in patients with type
1 DM.
The high serum levels of L-selectin have been
associated with different diseases in which the
microinflamation has an important part –
atherosclerosis, type 1 DM or DN in type 2 diabetic
patients >15]. The increase of serum levels of L-
selectin occurs as a consequence of its quick cleavage
on the leucocytes surface in the neighbouring area of
the trans-membrane domain, at the levels 346Lys and
347Ser. Thus the link between leucocytes and
endothelial cells can be quickly destroyed and they can
roll at the endothelium level [1]. In this fashion, when
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decreases on the leucocytes surface, entailing increase
of the serum soluble L-selectin level.
The relationship between the Pro213Ser
polymorphism and different diseases has been also
studied, and there have been found possible
associations of the 213Pro allele with DN in patients
with type 2 DM [12]. Also, certain researches could
not find evidence in the favour of allelic association
with diabetic retinopathy in type 2 DM [13] or with
nephropathies having other aetiology except DM [30].
The 213Pro allele was reported to be the risk allele
for the DN in type 2 diabetic patients. In our study, the
risk allele seems to be 213Ser allele. Therefore, it is
possible that the involvement of L-selectin in the
predisposition to these two affections to be achieved
by distinct mechanisms – in the first case by
microinflamation / atherosclerosis and in the second,
by means of the oligonephronia due to impaired
intrauterine development, followed by vulnerability to
outer deleterious agents.
As a conclusion, our results suggest a possible
association between the P213S polymorphism and
advanced stages of DN in type 1 diabetic patients.
Additional research will help us clarify the
mechanisms by which this polymorphism intervenes in
chronic complications of diabetes.
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